Oral fucose ameliorated DSS-induced colitis by lowering taurine-β-MCA (an FXR antagonist) and TCA, restoring the FXR-FGF15-CYP7A1 pathway, and increasing Lactobacillus. Here, NR1H4 is linked to colitis.